Durham, NC, United States of America

Zeljko Vusjaskovic

This inventor holds 1 USPTO granted patent. Top assignees: Aeolus Sciences, Inc., Duke University, National Jewish Medical and Research Center. Active years: 2014.


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zeljko Vusjaskovic: Innovator in Cancer Therapy

Introduction

Zeljko Vusjaskovic is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer therapy, particularly through his innovative methods involving low molecular weight antioxidants. His work aims to enhance the prevention and treatment of cancer, showcasing his dedication to improving healthcare outcomes.

Latest Patents

Zeljko Vusjaskovic holds 1 patent related to cancer therapy. This patent focuses on a method of preventing or treating cancer using low molecular weight antioxidants, such as mimetics of superoxide dismutase (SOD). The invention also encompasses compounds and compositions that are suitable for use in these therapeutic methods.

Career Highlights

Throughout his career, Zeljko has worked with prominent organizations, including Aeolus Sciences, Inc. and Duke University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Zeljko has collaborated with esteemed colleagues, including James D. Crapo and Brian J. Day. These partnerships have further enriched his research and development efforts in cancer therapy.

Conclusion

Zeljko Vusjaskovic is a dedicated inventor whose work in cancer therapy has the potential to make a significant impact on the treatment of this challenging disease. His innovative approach and collaborations highlight the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…